These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16911466

  • 1. Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study.
    Schepke M, Appenrodt B, Heller J, Zielinski J, Sauerbruch T.
    Liver Int; 2006 Sep; 26(7):834-9. PubMed ID: 16911466
    [Abstract] [Full Text] [Related]

  • 2. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.
    Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jiménez W, Arroyo V, Rodés J, Ginès P.
    Hepatology; 2005 Jun; 41(6):1282-9. PubMed ID: 15834937
    [Abstract] [Full Text] [Related]

  • 3. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI, Lin HC, Lee FY, Hou MC, Lee PC, Wu JC, Chang FY, Lee SD.
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [Abstract] [Full Text] [Related]

  • 4. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R.
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [Abstract] [Full Text] [Related]

  • 6. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [Abstract] [Full Text] [Related]

  • 7. Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis.
    Mathur S, Gane EJ, McCall JL, Plank LD.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):239-43. PubMed ID: 17489965
    [Abstract] [Full Text] [Related]

  • 8. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era.
    Ripoll C, Bañares R, Rincón D, Catalina MV, Lo Iacono O, Salcedo M, Clemente G, Núñez O, Matilla A, Molinero LM.
    Hepatology; 2005 Oct; 42(4):793-801. PubMed ID: 16175621
    [Abstract] [Full Text] [Related]

  • 9. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M.
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [Abstract] [Full Text] [Related]

  • 10. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA.
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [Abstract] [Full Text] [Related]

  • 11. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [Abstract] [Full Text] [Related]

  • 12. Model for end-stage liver disease (MELD) score as a useful prognostic marker in cirrhotic patients with infection.
    Khan R, Abid S, Jafri W, Awan S, Hamid S, Shah H, Pervez S.
    J Coll Physicians Surg Pak; 2009 Nov; 19(11):694-8. PubMed ID: 19889264
    [Abstract] [Full Text] [Related]

  • 13. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis.
    Serra MA, Puchades MJ, Rodríguez F, Escudero A, del Olmo JA, Wassel AH, Rodrigo JM.
    Scand J Gastroenterol; 2004 Nov; 39(11):1149-53. PubMed ID: 15545175
    [Abstract] [Full Text] [Related]

  • 14. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH, Sheppard BC, Schwartz J, Orloff SL.
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [Abstract] [Full Text] [Related]

  • 15. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels.
    Seo YS, Jung ES, An H, Kim JH, Jung YK, Kim JH, Yim HJ, Yeon JE, Byun KS, Kim CD, Ryu HS, Um SH.
    Liver Int; 2009 Nov; 29(10):1521-7. PubMed ID: 19725889
    [Abstract] [Full Text] [Related]

  • 16. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M, Hernández Perera JC, Ramos Robaina L, Barroso Márquez L, González Rapado L, Cepero Valdés M, Hernández Rivero H, Abdo Cuza A, Valdés AR, Pérez Bernal J, Bernardos A.
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [Abstract] [Full Text] [Related]

  • 17. Terlipressin therapy for renal failure in cirrhosis.
    Triantos CK, Samonakis D, Thalheimer U, Cholongitas E, Senzolo M, Marelli L, Leandro G, Patch D, Burroughs AK.
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):481-6. PubMed ID: 19952764
    [Abstract] [Full Text] [Related]

  • 18. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, Hou MC, Lee SD.
    Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
    [Abstract] [Full Text] [Related]

  • 19. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, Choudhuri G.
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [Abstract] [Full Text] [Related]

  • 20. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
    Londoño MC, Cárdenas A, Guevara M, Quintó L, de Las Heras D, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P.
    Gut; 2007 Sep; 56(9):1283-90. PubMed ID: 17452425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.